HF
REGN icon

HRT Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

HRT Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Sell
11,900
-7,200
-38% -$4.9M 0.01% 927
2026
Q1 		$14.8M Buy
19,100
+11,500
+151% +$8.8M 0.04% 462
2025
Q4 		$5.87M Buy
+7,600
New +$5.16M 0.02% 701
2023
Q2 		– Sell
-600
Closed -$493K – 3131
2023
Q1 		$493K Buy
+600
New +$453K 0.01% 1395

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HRT Financial's REGN Position: Q2 2026 in Review

HRT Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 36,092 shares worth $22.5M. The stake represents 0.04% of the portfolio and ranks #428 among its holdings. This is a return to the name: HRT Financial previously reported a position in REGN as recently as Q3 2025.

HRT Financial first reported a position in REGN in Q3 2015 and has held it in 18 quarters since. The position peaked at $55.6M in Q3 2025. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HRT Financial held 36,092 shares of Regeneron Pharmaceuticals worth $22.5M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.04% of HRT Financial's portfolio in Q2 2026, its #428 holding.
  • HRT Financial first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 18 quarters since.
  • HRT Financial's Regeneron Pharmaceuticals position peaked at $55.6M in Q3 2025.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.